Transfusion Increases the Risk for Vasoplegia After Cardiac Operations

被引:44
作者
Alfirevic, Andrej [1 ]
Xu, Meng
Johnston, Douglas
Figueroa, Priscilla
Koch, Colleen G.
机构
[1] Cleveland Clin, Dept Cardiothorac Anesthesiol J4, Inst Anesthesiol, Cleveland, OH 44195 USA
关键词
CONVERTING ENZYME-INHIBITORS; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; HYPOTENSIVE REACTIONS; ANESTHETIC INDUCTION; VASODILATORY SHOCK; METHYLENE-BLUE; OFF-PUMP; SURGERY; CELL;
D O I
10.1016/j.athoracsur.2011.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Perioperative vasoplegia is associated with increased morbidity. Red blood cell (RBC) transfusion increases plasma concentrations of inflammatory mediators, possibly contributing to the development of vasoplegia. We investigated the prevalence of mild and profound postoperative vasoplegia, identified factors associated with its development, and examined the role of RBC and component transfusion on the occurrence of postoperative vasoplegia. Methods. Between January 1, 2000, and January 1, 2007, 25,960 patients underwent on-bypass cardiac surgical procedures. The incidence of vasoplegia was defined as (1) mild vasoplegia requiring norepinephrine infusion for blood pressure support on the day of operation and postoperative day 1, and (2) profound vasoplegia requiring vasopressin, with or without concomitant norepinephrine infusion, on the day of operation and postoperative day 1. Separate logistic regression models were used to model risk factors for development of mild and profound vasoplegia. Results. RBC transfusion increased risk-adjusted odd ratios (ORs) of developing mild vasoplegia (1.07 [95% confidence limits (CL), 1.05, 1.10]; p < 0.001) and profound vasoplegia (1.38 [1.31, 1.46] p < 0.001). The risk-adjusted ORs (95% CL) for mild vasoplegia and profound vasoplegia were similarly increased by fresh-frozen plasma (OR, 1.24 [1.10, 1.41], p < 0.001; and OR, 1.20 [1.13, 1.29], p < 0.001) and platelet transfusion (OR, 1.39 [1.25, 1.54], p < 0.001; and OR, 1.22 [1.14, 1.31], p < 0.001), respectively. Conclusions. Red blood cells, fresh-frozen plasma, and platelet transfusion increased the prevalence of vasoplegia. RBC transfusion exhibited a dose-dependent response for developing vasoplegia with each RBC unit transfused. Further investigation is necessary to determine whether prophylactic use of vasopressor support in the setting of transfusion can ameliorate risk and effect outcomes. (Ann Thorac Surg 2011;92:812-20) (C) 2011 by The Society of Thoracic Surgeons
引用
收藏
页码:812 / 820
页数:9
相关论文
共 40 条
[1]   Transfusion Increases the Risk for Vasoplegia After Cardiac Operations [J].
Alfirevic, Andrej ;
Xu, Meng ;
Johnston, Douglas ;
Figueroa, Priscilla ;
Koch, Colleen G. .
ANNALS OF THORACIC SURGERY, 2011, 92 (03) :812-820
[2]  
Argenziano M, 1997, CIRCULATION, V96, P286
[3]   Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent [J].
Argenziano, M ;
Chen, JM ;
Choudhri, AF ;
Cullinane, S ;
Garfein, E ;
Weinberg, AD ;
Smith, CR ;
Rose, EA ;
Landry, DW ;
Oz, MC .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (06) :973-980
[4]   Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage [J].
Arnold, DM ;
Molinaro, G ;
Warkentin, TE ;
DiTomasso, J ;
Webert, KE ;
Davis, I ;
Lesiuk, L ;
Dunn, G ;
Heddle, NM ;
Adam, A ;
Blajchman, MA .
TRANSFUSION, 2004, 44 (09) :1361-+
[5]   Inflammatory response after coronary revascularization with or without cardiopulmonary bypass [J].
Ascione, R ;
Lloyd, CT ;
Underwood, MJ ;
Lotto, AA ;
Pitsis, AA ;
Angelini, GD .
ANNALS OF THORACIC SURGERY, 2000, 69 (04) :1198-1204
[6]  
Boyle EM, 1997, ANN THORAC SURG, V63, P277
[7]   The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists [J].
Brabant, SM ;
Bertrand, M ;
Eyraud, D ;
Darmon, PL ;
Coriat, P .
ANESTHESIA AND ANALGESIA, 1999, 89 (06) :1388-1392
[8]   Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology, and clinical importance [J].
Carrel, T ;
Engelberger, L ;
Mohacsi, P ;
Neidhart, P ;
Schmidli, J .
JOURNAL OF CARDIAC SURGERY, 2000, 15 (05) :347-353
[9]   Angiotensin system inhibitors in a general surgical population [J].
Comfere, T ;
Sprung, J ;
Kumar, MM ;
Draper, M ;
Wilson, DP ;
Williams, BA ;
Danielson, DR ;
Liedl, L ;
Warner, DO .
ANESTHESIA AND ANALGESIA, 2005, 100 (03) :636-644
[10]   Systemic inflammatory response syndrome after cardiac operations [J].
Cremer, J ;
Martin, M ;
Redl, H ;
Bahrami, S ;
Abraham, C ;
Graeter, T ;
Haverich, A ;
Schlag, G ;
Borst, HG .
ANNALS OF THORACIC SURGERY, 1996, 61 (06) :1714-1720